The profile of The collateral effects of antiepileptic drugs during pregnancy: a systematic review
- Categoria: Volume 77 - Julho/Dezembro de 2014
- Autor: Tainã Brito Siebra de Oliveira, Monique Leite Sampaio, Modesto Leite Rolim Neto
- Páginas: 21
- Preço: Faça o cadastro para download
- ISSN: 1807-9865
- Biblioteca: Neurobiologia
- Ano: 2014
- Link:
Comentário
The profile of The collateral effects of
antiepileptic drugs during pregnancy: a systematic review
Monique Leite Sampaio1*, Tainã Brito Siebra de Oliveira1,
Modesto Leite Rolim Neto1
abstract
The present study was based on the following critical question: What are the current trends in the prescription of antiepileptic drugs during pregnancy, taking into account the adverse effects presented by these drugs? A qualitative systematic review of articles about the antiepileptic and its adverse effects in pregnant women published in an electronic database previously chosen was performed. The literature search was conducted through Scopus online database in July 2014 and was limited to articles published between January 1, 2012 to July 22, 2014. The methods used to identify, select, evaluate and collect data from the analyzed studies were in accordance with the PRISMA Protocol for reviews and systematic meta-analyzes. According to The Cochrane Collaboration has published the PRISMA guidelines, medical research on the model of systematic reviews, which should be performed based on information that compose the acronym “PICOS” (patient, intervention, comparison, outcome, study design). In this article, ‘P’ is ‘pregnant’ or ‘children exposed ‘,’I’ as ‘drugs, planning’,
‘C’ variable in comparing the ‘P’ and ‘I’, ‘O’ ‘effects of drugs’, ‘S’ is exploratory field research and prospective
/ retrospective cohorts. Antiepileptic therapy is generally maintained during pregnancy due to the potential harm associated with the tonic-clonic convulsion. With careful planning of pregnancy and management of parturition a normal denouement is expected. It has been documented that pregnant women, including those with epilepsy, needs information about the teratogenic risk of drugs. Widnes et al demonstrates that pregnant women with epilepsy accepted the teratogenic risks of the DAE to achieve the therapeutic objectives during pregnancy.
Keywords: Antiepileptic Drugs. Pregnancy. Collateral Effects.